Figure 1.
CA199 of the patients was 4270 ng/mL before treatment with antilotinib, 2371 ng/mL after one treatment cycle, and 575.6 ng/mL after 4 treatment cycles.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.